Header Logo

James Chu

Concepts (162)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Radiotherapy Planning, Computer-Assisted
20
2018
68
3.760
Why?
Radiometry
16
2017
41
2.280
Why?
Phantoms, Imaging
10
2020
39
1.850
Why?
Brachytherapy
16
2019
56
1.800
Why?
Scattering, Radiation
8
2020
37
1.650
Why?
Radiosurgery
5
2020
38
1.620
Why?
Algorithms
8
2018
371
1.330
Why?
Monte Carlo Method
7
2018
52
1.100
Why?
Lung Neoplasms
3
2020
555
0.990
Why?
Uterine Cervical Neoplasms
3
2015
35
0.930
Why?
Radiotherapy Dosage
18
2018
117
0.910
Why?
Tomography, X-Ray Computed
5
2018
758
0.760
Why?
Radiotherapy, Image-Guided
2
2018
9
0.720
Why?
Molecular Imaging
1
2020
4
0.710
Why?
Computer Simulation
7
2018
205
0.650
Why?
Electrons
3
2009
18
0.620
Why?
Photons
1
2018
4
0.600
Why?
Models, Biological
3
2004
329
0.570
Why?
Breast Neoplasms
8
2017
417
0.550
Why?
Skin
2
2012
115
0.480
Why?
Magnetics
2
2005
3
0.470
Why?
Radiation Injuries
2
2012
32
0.410
Why?
Thermal Conductivity
1
2012
3
0.410
Why?
Particle Accelerators
3
2009
7
0.410
Why?
Thermography
1
2012
14
0.410
Why?
Whole-Body Irradiation
1
2012
11
0.400
Why?
Carcinoma, Squamous Cell
1
2013
177
0.390
Why?
Radiotherapy, Computer-Assisted
1
2011
3
0.370
Why?
Tomography, Spiral Computed
1
2011
27
0.370
Why?
Humans
32
2020
28054
0.360
Why?
Radiotherapy, Intensity-Modulated
3
2020
38
0.360
Why?
Sensitivity and Specificity
10
2015
511
0.350
Why?
Radiotherapy
3
2009
34
0.350
Why?
Computer-Aided Design
1
2009
15
0.340
Why?
Software
2
2011
66
0.330
Why?
Radiotherapy, Conformal
3
2005
21
0.330
Why?
Holography
1
2009
1
0.330
Why?
Quality Assurance, Health Care
3
2016
38
0.310
Why?
Catheterization
2
2005
45
0.310
Why?
Reproducibility of Results
9
2012
715
0.270
Why?
Imaging, Three-Dimensional
4
2011
229
0.260
Why?
Software Validation
1
2005
1
0.250
Why?
Cardiac Surgical Procedures
1
2005
45
0.250
Why?
Equipment Design
8
2012
153
0.240
Why?
Prostatic Neoplasms
2
2018
103
0.240
Why?
Surgery, Computer-Assisted
1
2005
53
0.240
Why?
Neurosurgical Procedures
1
2005
128
0.220
Why?
Posture
1
2003
68
0.220
Why?
Ethmoid Sinus
1
2003
10
0.220
Why?
Stents
5
2004
85
0.220
Why?
Lung
1
2003
170
0.200
Why?
Intraoperative Care
2
2017
43
0.200
Why?
Female
17
2015
15534
0.180
Why?
Electrical Equipment and Supplies
1
2019
2
0.170
Why?
Research Report
1
2019
7
0.170
Why?
Equipment Failure Analysis
5
2012
110
0.160
Why?
Coronary Restenosis
3
2004
11
0.160
Why?
Graft Occlusion, Vascular
3
2004
21
0.160
Why?
Body Burden
2
2012
7
0.160
Why?
Societies, Medical
1
2019
153
0.160
Why?
Four-Dimensional Computed Tomography
1
2018
5
0.150
Why?
Proton Therapy
1
2018
2
0.150
Why?
Acoustics
1
2018
19
0.150
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2018
30
0.150
Why?
Liver Neoplasms
1
2018
105
0.130
Why?
Strontium Radioisotopes
4
2003
9
0.130
Why?
Radiation Dosage
1
2015
38
0.120
Why?
Intestine, Small
1
2015
33
0.120
Why?
Angioplasty, Balloon, Coronary
3
2004
39
0.120
Why?
Gamma Rays
1
2015
17
0.120
Why?
Beta Particles
3
2003
8
0.110
Why?
Treatment Outcome
8
2013
3530
0.110
Why?
Organs at Risk
1
2013
9
0.110
Why?
Rectum
1
2013
45
0.110
Why?
Urinary Bladder
1
2013
22
0.110
Why?
Decision Support Techniques
1
2013
51
0.110
Why?
Risk Assessment
4
2019
664
0.110
Why?
Head and Neck Neoplasms
1
2015
151
0.110
Why?
Radiotherapy, Adjuvant
3
2017
52
0.110
Why?
Artifacts
2
2011
33
0.100
Why?
X-Ray Film
1
2011
3
0.090
Why?
Surveys and Questionnaires
1
2016
1201
0.090
Why?
Mice
2
2012
1494
0.090
Why?
Pilot Projects
1
2012
432
0.090
Why?
Calibration
1
2009
20
0.080
Why?
Metals
1
2011
152
0.080
Why?
Radiographic Image Enhancement
1
2009
27
0.080
Why?
Biomarkers
1
2012
581
0.080
Why?
Image Interpretation, Computer-Assisted
1
2009
69
0.080
Why?
Quality Control
3
2019
33
0.080
Why?
Brain Neoplasms
1
2009
89
0.080
Why?
Animals
2
2012
3824
0.070
Why?
Radiotherapy, High-Energy
2
2003
4
0.070
Why?
Middle Aged
9
2005
9186
0.070
Why?
Esthetics
1
2005
12
0.060
Why?
Iridium Radioisotopes
1
2005
4
0.060
Why?
Coronary Angiography
2
2003
76
0.060
Why?
Bacterial Infections
1
2005
52
0.060
Why?
Radiation Protection
1
2004
5
0.060
Why?
Heart Transplantation
1
2004
30
0.060
Why?
Relative Biological Effectiveness
1
2004
5
0.060
Why?
Contrast Media
1
2004
72
0.060
Why?
Coronary Stenosis
1
2004
16
0.060
Why?
Supine Position
1
2003
19
0.060
Why?
Models, Statistical
1
2004
128
0.050
Why?
Prone Position
1
2003
34
0.050
Why?
Anisotropy
1
2003
53
0.050
Why?
Reference Values
1
2003
201
0.050
Why?
Aged
7
2005
9222
0.050
Why?
Combined Modality Therapy
1
2003
306
0.050
Why?
Visual Perception
1
2002
35
0.050
Why?
Follow-Up Studies
5
2006
1809
0.050
Why?
Mastectomy, Segmental
3
2005
31
0.050
Why?
Neoplasms
1
2003
236
0.040
Why?
Workflow
1
2019
10
0.040
Why?
Male
7
2018
15143
0.040
Why?
Prospective Studies
4
2005
1748
0.040
Why?
Water
1
2017
32
0.040
Why?
Adult
3
2005
8021
0.030
Why?
Automation
1
2016
9
0.030
Why?
Dose-Response Relationship, Radiation
2
2006
10
0.030
Why?
Internet
1
2016
95
0.030
Why?
Severity of Illness Index
3
2004
990
0.030
Why?
Body Water
1
2012
3
0.030
Why?
Mice, Hairless
1
2012
3
0.030
Why?
Tomography
1
2012
13
0.030
Why?
Blood Vessel Prosthesis Implantation
2
2003
21
0.030
Why?
Radiography
2
2004
640
0.020
Why?
Survival Rate
2
2004
354
0.020
Why?
Incidence
2
2005
750
0.020
Why?
Logistic Models
1
2012
395
0.020
Why?
Myocardial Infarction
2
2003
140
0.020
Why?
Randomized Controlled Trials as Topic
2
2003
319
0.020
Why?
Predictive Value of Tests
2
2003
492
0.020
Why?
Models, Anatomic
1
2009
44
0.020
Why?
Age Distribution
1
2005
89
0.020
Why?
Aged, 80 and over
2
2005
4846
0.020
Why?
Survival Analysis
1
2005
265
0.020
Why?
Evaluation Studies as Topic
1
2005
36
0.020
Why?
Angiography
1
2004
33
0.010
Why?
Radiology, Interventional
1
2004
6
0.010
Why?
Single-Blind Method
1
2004
111
0.010
Why?
Retrospective Studies
2
2003
3524
0.010
Why?
Endpoint Determination
1
2003
22
0.010
Why?
Film Dosimetry
1
2003
2
0.010
Why?
Statistics as Topic
1
2003
116
0.010
Why?
Myocardial Revascularization
1
2003
16
0.010
Why?
Miniaturization
1
2002
2
0.010
Why?
Treatment Failure
1
2003
162
0.010
Why?
Death
1
2003
47
0.010
Why?
Illinois
1
2003
245
0.010
Why?
Multivariate Analysis
1
2003
319
0.010
Why?
Platelet Glycoprotein GPIIb-IIIa Complex
1
2002
7
0.010
Why?
Angioplasty, Balloon
1
2002
13
0.010
Why?
Feasibility Studies
1
2002
231
0.010
Why?
Random Allocation
1
2002
129
0.010
Why?
Recurrence
1
2002
318
0.010
Why?
Coronary Artery Disease
1
2003
138
0.010
Why?
Clinical Trials as Topic
1
2002
234
0.010
Why?
Cohort Studies
1
2005
1882
0.010
Why?
Risk Factors
1
2004
2371
0.010
Why?
Reoperation
1
2002
906
0.010
Why?
Chu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (162)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_